These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 11870868

  • 1. Noncovalent interaction energies in covalent complexes: TEM-1 beta-lactamase and beta-lactams.
    Wang X, Minasov G, Shoichet BK.
    Proteins; 2002 Apr 01; 47(1):86-96. PubMed ID: 11870868
    [Abstract] [Full Text] [Related]

  • 2. Functional analyses of AmpC beta-lactamase through differential stability.
    Beadle BM, McGovern SL, Patera A, Shoichet BK.
    Protein Sci; 1999 Sep 01; 8(9):1816-24. PubMed ID: 10493583
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of AmpC beta-lactamase through a destabilizing interaction in the active site.
    Trehan I, Beadle BM, Shoichet BK.
    Biochemistry; 2001 Jul 10; 40(27):7992-9. PubMed ID: 11434768
    [Abstract] [Full Text] [Related]

  • 4. Interaction energies between beta-lactam antibiotics and E. coli penicillin-binding protein 5 by reversible thermal denaturation.
    Beadle BM, Nicholas RA, Shoichet BK.
    Protein Sci; 2001 Jun 10; 10(6):1254-9. PubMed ID: 11369864
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS, Blázquez J, Baquero F, Shoichet BK.
    J Med Chem; 1998 Nov 05; 41(23):4577-86. PubMed ID: 9804697
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A theoretical study on the substrate deacylation mechanism of class C beta-lactamase.
    Hata M, Tanaka Y, Fujii Y, Neya S, Hoshino T.
    J Phys Chem B; 2005 Aug 25; 109(33):16153-60. PubMed ID: 16853052
    [Abstract] [Full Text] [Related]

  • 9. Thermodynamic cycle analysis and inhibitor design against beta-lactamase.
    Roth TA, Minasov G, Morandi S, Prati F, Shoichet BK.
    Biochemistry; 2003 Dec 16; 42(49):14483-91. PubMed ID: 14661960
    [Abstract] [Full Text] [Related]

  • 10. X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.
    Swarén P, Golemi D, Cabantous S, Bulychev A, Maveyraud L, Mobashery S, Samama JP.
    Biochemistry; 1999 Jul 27; 38(30):9570-6. PubMed ID: 10423234
    [Abstract] [Full Text] [Related]

  • 11. Toward better antibiotics: crystallographic studies of a novel class of DD-peptidase/beta-lactamase inhibitors.
    Silvaggi NR, Kaur K, Adediran SA, Pratt RF, Kelly JA.
    Biochemistry; 2004 Jun 08; 43(22):7046-53. PubMed ID: 15170342
    [Abstract] [Full Text] [Related]

  • 12. Recognition and resistance in TEM beta-lactamase.
    Wang X, Minasov G, Blázquez J, Caselli E, Prati F, Shoichet BK.
    Biochemistry; 2003 Jul 22; 42(28):8434-44. PubMed ID: 12859188
    [Abstract] [Full Text] [Related]

  • 13. Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem.
    Pernot L, Frénois F, Rybkine T, L'Hermite G, Petrella S, Delettré J, Jarlier V, Collatz E, Sougakoff W.
    J Mol Biol; 2001 Jul 20; 310(4):859-74. PubMed ID: 11453693
    [Abstract] [Full Text] [Related]

  • 14. Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: possible implications for the oxyanion hypothesis and for inhibitor design.
    Usher KC, Blaszczak LC, Weston GS, Shoichet BK, Remington SJ.
    Biochemistry; 1998 Nov 17; 37(46):16082-92. PubMed ID: 9819201
    [Abstract] [Full Text] [Related]

  • 15. Increased folding stability of TEM-1 beta-lactamase by in vitro selection.
    Kather I, Jakob RP, Dobbek H, Schmid FX.
    J Mol Biol; 2008 Oct 31; 383(1):238-51. PubMed ID: 18706424
    [Abstract] [Full Text] [Related]

  • 16. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH, Chan KC, Liu HB, Chung WH, Leung YC, Wong KY.
    Anal Chem; 2005 Aug 15; 77(16):5268-76. PubMed ID: 16097768
    [Abstract] [Full Text] [Related]

  • 17. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ, Cartelle M, Mallo S, Beceiro A, Pérez A, Villanueva R, Romero A, Bonnet R, Bou G.
    J Antimicrob Chemother; 2008 Apr 15; 61(4):792-7. PubMed ID: 18281307
    [Abstract] [Full Text] [Related]

  • 18. Fluorophore-labeled beta-lactamase as a biosensor for beta-lactam antibiotics: a study of the biosensing process.
    Chan PH, So PK, Ma DL, Zhao Y, Lai TS, Chung WH, Chan KC, Yiu KF, Chan HW, Siu FM, Tsang CW, Leung YC, Wong KY.
    J Am Chem Soc; 2008 May 21; 130(20):6351-61. PubMed ID: 18429614
    [Abstract] [Full Text] [Related]

  • 19. Crystal structures of complexes between the R61 DD-peptidase and peptidoglycan-mimetic beta-lactams: a non-covalent complex with a "perfect penicillin".
    Silvaggi NR, Josephine HR, Kuzin AP, Nagarajan R, Pratt RF, Kelly JA.
    J Mol Biol; 2005 Jan 21; 345(3):521-33. PubMed ID: 15581896
    [Abstract] [Full Text] [Related]

  • 20. Crystal structure of extended-spectrum beta-lactamase Toho-1: insights into the molecular mechanism for catalytic reaction and substrate specificity expansion.
    Ibuka AS, Ishii Y, Galleni M, Ishiguro M, Yamaguchi K, Frère JM, Matsuzawa H, Sakai H.
    Biochemistry; 2003 Sep 16; 42(36):10634-43. PubMed ID: 12962487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.